PensionDanmark Pensionsforsikringsaktieselskab cut its stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) by 2.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 100,250 shares of the financial services provider’s stock after selling 2,780 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Marsh & McLennan Companies were worth $16,709,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Marsh & McLennan Companies by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 46,589,633 shares of the financial services provider’s stock worth $8,643,309,000 after buying an additional 387,100 shares in the last quarter. State Street Corp bought a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth $4,057,682,000. Capital International Investors acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at $3,482,557,000. Capital World Investors bought a new position in Marsh & McLennan Companies in the fourth quarter valued at about $3,140,284,000. Finally, Wellington Management Group LLP acquired a new stake in Marsh & McLennan Companies in the fourth quarter worth about $2,967,927,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the stock. Mizuho raised their target price on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a “neutral” rating in a research note on Wednesday, July 22nd. Bank of America dropped their target price on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research report on Tuesday, April 14th. UBS Group upped their price objective on Marsh & McLennan Companies from $212.00 to $216.00 and gave the company a “buy” rating in a report on Monday, July 27th. Keefe, Bruyette & Woods upped their price target on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research note on Friday, April 17th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $201.94.
Insider Buying and Selling at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Paul Beswick sold 713 shares of Marsh & McLennan Companies stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $198.00, for a total transaction of $141,174.00. Following the completion of the sale, the senior vice president owned 16,376 shares in the company, valued at $3,242,448. The trade was a 4.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 36,469 shares of company stock worth $6,291,345. Company insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Shares of MRSH stock opened at $191.31 on Friday. The firm has a market cap of $91.30 billion, a P/E ratio of 23.39, a P/E/G ratio of 2.77 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $213.80. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The business’s 50 day moving average is $175.15.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.Marsh & McLennan Companies’s revenue for the quarter was up 6.2% on a year-over-year basis. Analysts forecast that Marsh & McLennan Companies, Inc. will post 10.43 earnings per share for the current year.
Marsh & McLennan Companies Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd will be given a $0.99 dividend. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. This represents a $3.96 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, July 23rd. Marsh & McLennan Companies’s payout ratio is presently 48.41%.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
